Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Falardeau

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Trends in Pharmacological Sciences|June 1, 1990
Dopamine receptor subtypes: beyond the D1/D2 classificationP H Andersen, J A Gingrich, M D Bates, et al.
Biochemical Pharmacology|July 27, 2010
TLN-4601 peripheral benzodiazepine receptor (PBR/TSPO) binding properties do not mediate apoptosis but confer tumor-specific accumulationT Bertomeu, V Zvereff, A Ibrahim, et al.
American Journal of Hypertension|June 1, 1990
Molecular characterization of dopamine receptorsM D Bates, J A Gingrich, J R Bunzow, et al.
Journal of Cutaneous Medicine and Surgery|February 8, 2003
Modulation of the contact hypersensitivity response by AE-941 (Neovastat), a novel antiangiogenic agentE Dupont, B Wang, A J Mamelak, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 1991
Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptorM Tiberi, K R Jarvie, C Silvia, et al.
Molecular Psychiatry|December 29, 2000
Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine usersJ N Worsley, A Moszczynska, P Falardeau, et al.
Nature Genetics|August 11, 1998
Homozygotes carrying an autosomal dominant TIGR mutation do not manifest glaucomaJ Morissette, C Clépet, S Moisan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 24, 1999
Pathophysiology of L-dopa-induced dyskinesiasP J Bédard, P J Blanchet, D Lévesque, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Trends in Pharmacological Sciences|June 1, 1990
Dopamine receptor subtypes: beyond the D1/D2 classificationP H Andersen, J A Gingrich, M D Bates, et al.
Biochemical Pharmacology|July 27, 2010
TLN-4601 peripheral benzodiazepine receptor (PBR/TSPO) binding properties do not mediate apoptosis but confer tumor-specific accumulationT Bertomeu, V Zvereff, A Ibrahim, et al.
American Journal of Hypertension|June 1, 1990
Molecular characterization of dopamine receptorsM D Bates, J A Gingrich, J R Bunzow, et al.
Journal of Cutaneous Medicine and Surgery|February 8, 2003
Modulation of the contact hypersensitivity response by AE-941 (Neovastat), a novel antiangiogenic agentE Dupont, B Wang, A J Mamelak, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 1991
Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptorM Tiberi, K R Jarvie, C Silvia, et al.
Molecular Psychiatry|December 29, 2000
Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine usersJ N Worsley, A Moszczynska, P Falardeau, et al.
Nature Genetics|August 11, 1998
Homozygotes carrying an autosomal dominant TIGR mutation do not manifest glaucomaJ Morissette, C Clépet, S Moisan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 24, 1999
Pathophysiology of L-dopa-induced dyskinesiasP J Bédard, P J Blanchet, D Lévesque, et al.
Pageof 8